General information about company |
|||
|---|---|---|---|
| Scrip Code | 500136 | ||
| NSE Symbol | ESTER | ||
| MSEI Symbol | NOTLISTED | ||
| ISIN | INE778B01029 | ||
| Name of company | ESTER INDUSTRIES LIMITED | ||
| Type of company | Main Board | ||
| Class of security | Equity | ||
| Date of start of financial year | 01-Apr-2024 | ||
| Date of end of financial year | 31-Mar-2025 | ||
| Date of board meeting when results were approved | 21-May-2025 | ||
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 16-May-2025 | ||
| Description of presentation currency | INR (in Actuals) | ||
| Reporting Type | Quarterly | ||
| Reporting Quarter | Fourth quarter | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Whether results are audited or unaudited for the quarter ended | Audited | ||
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Audited | ||
| Segment Reporting | Multi segment | ||
| Description of single segment | |||
| Start date and time of board meeting | 21-May-2025 19:30:00 | ||
| End date and time of board meeting | 21-May-2025 20:15:00 | ||
| Whether cash flow statement is applicable on company | Yes | ||
| Type of cash flow statement | Cash Flow Indirect | ||
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion | ||
Financial Results Ind-AS |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 |
| B | Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. | ||
| 1 | Income | ||
| Revenue from operations | 3192557000 | 12821421000 | |
| Other income | 26604000 | 168986000 | |
| Total income | 3219161000 | 12990407000 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 1944970000 | 7924511000 |
| (b) | Purchases of stock-in-trade | 0 | 0 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 14173000 | 24859000 |
| (d) | Employee benefit expense | 179904000 | 711545000 |
| (e) | Finance costs | 156583000 | 673269000 |
| (f) | Depreciation, depletion and amortisation expense | 170893000 | 687525000 |
| (f) | Other Expenses | ||
| 1 | Other Expenses | 686883000 | 2688594000 |
| Total other expenses | 686883000 | 2688594000 | |
| Total expenses | 3153406000 | 12710303000 | |
| 3 | Total profit before exceptional items and tax | 65755000 | 280104000 |
| 4 | Exceptional items | -2041000 | -2041000 |
| 5 | Total profit before tax | 63714000 | 278063000 |
| 6 | Tax expense | ||
| 7 | Current tax | 33665000 | 44226000 |
| 8 | Deferred tax | 10436000 | 96855000 |
| 9 | Total tax expenses | 44101000 | 141081000 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0 | 0 |
| 11 | Net Profit Loss for the period from continuing operations | 19613000 | 136982000 |
| 12 | Profit (loss) from discontinued operations before tax | 0 | 0 |
| 13 | Tax expense of discontinued operations | 0 | 0 |
| 14 | Net profit (loss) from discontinued operation after tax | 0 | 0 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0 | 0 |
| 16 | Total profit (loss) for period | 19613000 | 136982000 |
| 17 | Other comprehensive income net of taxes | -2641000 | -36096000 |
| 18 | Total Comprehensive Income for the period | 16972000 | 100886000 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 0 | 0 | |
| Total profit or loss, attributable to non-controlling interests | 0 | 0 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 0 | 0 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 0 | 0 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 470209000 | 470209000 | |
| Face value of equity share capital | 5 | 5 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | 0 | |
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 0.21 | 1.46 | |
| Diluted earnings (loss) per share from continuing operations | 0.21 | 1.46 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 0.21 | 1.46 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 0.21 | 1.46 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Due to restriction of 4000 words, we are unable to paste all Notes in the Standalone Audited Financial Results XBRL. n nNotes on the Audited Financial results are same as mentioned in the pdf uploaded on 21.05.2025 under Outcome of Board meeting on the Stock Exchanges. | |
Remarks |
|
|---|---|
| Debt equity ratio | |
| Debt service coverage ratio | |
| Interest service coverage ratio | |
Statement of Asset and Liabilities |
|||
|---|---|---|---|
| Particulars | Year ended (dd-mm-yyyy) | ||
| Date of start of reporting period | 01-Apr-2024 | ||
| Date of end of reporting period | 31-Mar-2025 | ||
| Whether results are audited or unaudited | Audited | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Assets | |||
| 1 | Non-current assets | ||
| Property, plant and equipment | 9768356000 | ||
| Capital work-in-progress | 392186000 | ||
| Investment property | 0 | ||
| Goodwill | 0 | ||
| Other intangible assets | 4520000 | ||
| Intangible assets under development | 0 | ||
| Biological assets other than bearer plants | 0 | ||
| Investments accounted for using equity method | 0 | ||
| Non-current financial assets | |||
| Non-current investments | 0 | ||
| Trade receivables, non-current | 0 | ||
| Loans, non-current | 2487000 | ||
| Other non-current financial assets | 323276000 | ||
| Total non-current financial assets | 325763000 | ||
| Deferred tax assets (net) | 14735000 | ||
| Other non-current assets | 170786000 | ||
| Total non-current assets | 10676346000 | ||
| 2 | Current assets | ||
| Inventories | 1614219000 | ||
| Current financial asset | |||
| Current investments | 580128000 | ||
| Trade receivables, current | 1703362000 | ||
| Cash and cash equivalents | 225639000 | ||
| Bank balance other than cash and cash equivalents | 454787000 | ||
| Loans, current | 6412000 | ||
| Other current financial assets | 19836000 | ||
| Total current financial assets | 2990164000 | ||
| Current tax assets (net) | 0 | ||
| Other current assets | 448388000 | ||
| Total current assets | 5052771000 | ||
| 3 | Non-current assets classified as held for sale | 0 | |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | 0 | |
| Total assets | 15729117000 | ||
| Equity and liabilities | |||
| 1 | Equity | ||
| Equity attributable to owners of parent | |||
| Equity share capital | 470209000 | ||
| Other equity | 7254988000 | ||
| Total equity attributable to owners of parent | 7725197000 | ||
| Non controlling interest | 0 | ||
| Total equity | 7725197000 | ||
| 2 | Liabilities | ||
| Non-current liabilities | |||
| Non-current financial liabilities | |||
| Borrowings, non-current | 4047969000 | ||
| Trade payables, non-current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 0 | ||
| Total Trade payable | 0 | ||
| Other non-current financial liabilities | 0 | ||
| Total non-current financial liabilities | 4047969000 | ||
| Provisions, non-current | 102684000 | ||
| Deferred tax liabilities (net) | 246809000 | ||
| Deferred government grants, Non-current | 0 | ||
| Other non-current liabilities | 287911000 | ||
| Total non-current liabilities | 4685373000 | ||
| Current liabilities | |||
| Current financial liabilities | |||
| Borrowings, current | 2553815000 | ||
| Trade payables, current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 92228000 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 378196000 | ||
| Total Trade payable | 470424000 | ||
| Other current financial liabilities | 167826000 | ||
| Total current financial liabilities | 3192065000 | ||
| Other current liabilities | 69135000 | ||
| Provisions, current | 45301000 | ||
| Current tax liabilities (Net) | 12046000 | ||
| Deferred government grants, Current | 0 | ||
| Total current liabilities | 3318547000 | ||
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | 0 | |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | 0 | |
| Total liabilities | 8003920000 | ||
| Total equity and liabilites | 15729117000 | ||
| Disclosure of notes on assets and liabilities | |||
Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results |
|||||||
|---|---|---|---|---|---|---|---|
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
| Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 | |||||
| Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 | |||||
| Whether accounts are audited or unaudited | Audited | Audited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| 1 | Polyester chips and film | 2708644000 | 11104811000 | ||||
| 2 | Speciality polymers | 483913000 | 1716610000 | ||||
| Total Segment Revenue | 3192557000 | 12821421000 | |||||
| Less: Inter segment revenue | 0 | 0 | |||||
| Revenue from operations | 3192557000 | 12821421000 | |||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| 1 | Polyester chips and film | 234920000 | 917954000 | ||||
| 2 | Speciality polymers | 135743000 | 579130000 | ||||
| Total Profit before tax | 370663000 | 1497084000 | |||||
| i. Finance cost | 156583000 | 156583000 | |||||
| ii. Other Unallocable Expenditure net off Unallocable income | 150366000 | 150366000 | |||||
| Profit before tax | 63714000 | 278063000 | |||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| 1 | Polyester chips and film | 11511238000 | 11511238000 | ||||
| 2 | Speciality polymers | 1315279000 | 1315279000 | ||||
| Total Segment Asset | 12826517000 | 12826517000 | |||||
| Un-allocable Assets | 2902600000 | 2902600000 | |||||
| Net Segment Asset | 15729117000 | 15729117000 | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| 1 | Polyester chips and film | 4509088000 | 4509088000 | ||||
| 2 | Speciality polymers | 63322000 | 63322000 | ||||
| Total Segment Liabilities | 4572410000 | 4572410000 | |||||
| Un-allocable Liabilities | 3431510000 | 3431510000 | |||||
| Net Segment Liabilities | 8003920000 | 8003920000 | |||||
| Disclosure of notes on segments | |||||||
Other Comprehensive Income |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 |
| B | Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Acturial (loss) on remeasurement of defined benefit plan | -1596000 | -7124000 |
| Total Amount of items that will not be reclassified to profit and loss | -1596000 | -7124000 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | -441000 | -1763000 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Effective portion of (loss)/gain on hedging instruments in cash flow hedge | -2881000 | -42363000 |
| 2 | Effective portion of (loss)/gain on hedging instruments in cost of hedge | 560000 | 690000 |
| Total Amount of items that will be reclassified to profit and loss | -2321000 | -41673000 | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | -835000 | -10938000 |
| 5 | Total Other comprehensive income | -2641000 | -36096000 |
Cash flow statement, indirect |
||||||
|---|---|---|---|---|---|---|
| Particulars | Year ended (dd-mm-yyyy) | |||||
| A | Date of start of reporting period | 2024-04-01 | ||||
| B | Date of end of reporting period | 2025-03-31 | ||||
| C | Whether results are audited or unaudited | Audited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Part I | Blue color marked fields are non-mandatory. | |||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | 278063000 | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 597221000 | |||||
| Adjustments for decrease (increase) in inventories | -168185000 | |||||
| Adjustments for decrease (increase) in trade receivables, current | -244545000 | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0 | |||||
| Adjustments for decrease (increase) in other current assets | 0 | |||||
| Adjustments for decrease (increase) in other non-current assets | 195813000 | |||||
| Adjustments for other financial assets, non-current | -10756000 | |||||
| Adjustments for other financial assets, current | 0 | |||||
| Adjustments for other bank balances | 0 | |||||
| Adjustments for increase (decrease) in trade payables, current | -159081000 | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0 | |||||
| Adjustments for increase (decrease) in other current liabilities | 0 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0 | |||||
| Adjustments for depreciation and amortisation expense | 687525000 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0 | |||||
| Adjustments for provisions, current | -579000 | |||||
| Adjustments for provisions, non-current | 0 | |||||
| Adjustments for other financial liabilities, current | 12902000 | |||||
| Adjustments for other financial liabilities, non-current | 143000 | |||||
| Adjustments for unrealised foreign exchange losses gains | 50994000 | |||||
| Adjustments for dividend income | 0 | |||||
| Adjustments for interest income | 70496000 | |||||
| Adjustments for share-based payments | 2149000 | |||||
| Adjustments for fair value losses (gains) | -7624000 | |||||
| Adjustments for undistributed profits of associates | 0 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | -20606000 | |||||
| Other adjustments to reconcile profit (loss) | 0 | |||||
| Other adjustments for non-cash items | 8702000 | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Total adjustments for reconcile profit (loss) | 873577000 | |||||
| Net cash flows from (used in) operations | 1151640000 | |||||
| Dividends received | 0 | |||||
| Interest paid | 0 | |||||
| Interest received | 0 | |||||
| Income taxes paid (refund) | 29692000 | |||||
| Other inflows (outflows) of cash | 0 | |||||
| Net cash flows from (used in) operating activities | 1121948000 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 860424000 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 732361000 | |||||
| Other cash receipts from sales of interests in joint ventures | 0 | |||||
| Other cash payments to acquire interests in joint ventures | 0 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Proceeds from sales of property, plant and equipment | 0 | |||||
| Purchase of property, plant and equipment | 310041000 | |||||
| Proceeds from sales of investment property | 12671000 | |||||
| Purchase of investment property | 0 | |||||
| Proceeds from sales of intangible assets | 0 | |||||
| Purchase of intangible assets | 0 | |||||
| Proceeds from sales of intangible assets under development | 0 | |||||
| Purchase of intangible assets under development | 0 | |||||
| Proceeds from sales of goodwill | 0 | |||||
| Purchase of goodwill | 0 | |||||
| Proceeds from biological assets other than bearer plants | 0 | |||||
| Purchase of biological assets other than bearer plants | 0 | |||||
| Proceeds from government grants | 0 | |||||
| Proceeds from sales of other long-term assets | 0 | |||||
| Purchase of other long-term assets | 0 | |||||
| Cash advances and loans made to other parties | 0 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0 | |||||
| Dividends received | 0 | |||||
| Interest received | 64201000 | |||||
| Income taxes paid (refund) | 0 | |||||
| Other inflows (outflows) of cash | -459738000 | |||||
| Net cash flows from (used in) investing activities | -564844000 | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0 | |||||
| Payments from changes in ownership interests in subsidiaries | 0 | |||||
| Proceeds from issuing shares | 9227000 | |||||
| Proceeds from issuing other equity instruments | 0 | |||||
| Payments to acquire or redeem entity's shares | 0 | |||||
| Payments of other equity instruments | 0 | |||||
| Proceeds from exercise of stock options | 0 | |||||
| Proceeds from issuing debentures notes bonds etc | 0 | |||||
| Proceeds from borrowings | 637621000 | |||||
| Repayments of borrowings | 1835844000 | |||||
| Payments of lease liabilities | 0 | |||||
| Dividends paid | 0 | |||||
| Interest paid | 579613000 | |||||
| Income taxes paid (refund) | 0 | |||||
| Other inflows (outflows) of cash | 437485000 | |||||
| Net cash flows from (used in) financing activities | -1331124000 | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | -774020000 | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 999659000 | |||||
| Net increase (decrease) in cash and cash equivalents | 225639000 | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 0 | |||||
| Cash and cash equivalents cash flow statement at end of period | 225639000 | |||||
Details of Impact of Audit Qualification |
|
|---|---|
| Whether results are audited or unaudited | Audited |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | Walker Chandiok & Co. LLP | Yes | 31-May-2028 | ||
|---|---|---|---|---|---|
Financial details |
|||
| Sr. | Particulars | Audited Figures (as reported before adjusting for qualifications) | Adjusted Figures (audited figures after adjusting for qualifications) |
| 1 | Turnover / Total income | ||
| 2 | Total Expenditure | ||
| 3 | Net Profit/(Loss) | ||
| 4 | Earnings Per Share | ||
| 5 | Total Assets | ||
| 6 | Total Liabilities | ||
| 7 | Net Worth | ||
Signatories detail |
|
|---|---|
| Name of CEO / Managing director | |
| Name of CFO | |
| Name of audit committee chairman | |
| Name of statutory auditor | |
| Name of other signatory, if any, with designation | |
| Place | |
| Date | |